GNK Q1 2026 Earnings Massive EPS Beat Driven by Strong Market Conditions IMA Q1 2026 Earnings EPS Misses Estimates as PreRevenue Biotech Advances Pipeline Intrepid Potash IPI Q1 2026 Earnings EPS Surges Past Estimates with 2789 Beat MDLN Q1 2026 Earnings Strong EPS Beat Drives Positive Market Response CCNEP Q1 2026 Earnings EPS Surpasses Estimates Despite Modest Stock Decline Recursion Pharmaceuticals RXRX Q1 2026 Earnings Narrower Loss Surprises Market but Stock Dips on PreRevenue Status